What Are the Latest Developments in Targeted Therapies?
Targeted therapies aim to attack specific cancer cell markers, sparing normal cells and reducing side effects. Recent developments include drugs that target the BRCA mutations in breast and ovarian cancers, as well as therapies targeting EGFR mutations in lung cancer. The advent of precision medicine has facilitated the customization of these treatments based on individual genetic profiles, enhancing efficacy.
